Pharvaris (NASDAQ:PHVS - Get Free Report) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 487,300 shares, an increase of 24.7% from the February 13th total of 390,900 shares. Currently, 2.8% of the company's stock are sold short. Based on an average trading volume of 55,500 shares, the days-to-cover ratio is currently 8.8 days.
Analyst Upgrades and Downgrades
Separately, JMP Securities upped their price target on Pharvaris from $46.00 to $55.00 and gave the stock a "market outperform" rating in a research note on Friday, January 31st.
Read Our Latest Stock Analysis on Pharvaris
Pharvaris Trading Up 2.4 %
NASDAQ:PHVS traded up $0.38 during mid-day trading on Friday, hitting $15.84. 3,629 shares of the company's stock traded hands, compared to its average volume of 70,030. The firm has a 50 day moving average of $16.92 and a two-hundred day moving average of $19.06. Pharvaris has a 12 month low of $14.14 and a 12 month high of $25.80. The firm has a market capitalization of $828.01 million, a price-to-earnings ratio of -5.66 and a beta of -3.02.
Hedge Funds Weigh In On Pharvaris
A number of hedge funds have recently modified their holdings of the stock. FMR LLC raised its holdings in shares of Pharvaris by 3.6% in the 4th quarter. FMR LLC now owns 5,395,370 shares of the company's stock worth $103,429,000 after buying an additional 189,714 shares in the last quarter. Soleus Capital Management L.P. raised its holdings in shares of Pharvaris by 36.2% in the 4th quarter. Soleus Capital Management L.P. now owns 814,652 shares of the company's stock worth $15,617,000 after buying an additional 216,483 shares in the last quarter. Octagon Capital Advisors LP raised its holdings in shares of Pharvaris by 25.4% in the 4th quarter. Octagon Capital Advisors LP now owns 778,000 shares of the company's stock worth $14,914,000 after buying an additional 157,530 shares in the last quarter. Rock Springs Capital Management LP raised its holdings in shares of Pharvaris by 2.4% in the 4th quarter. Rock Springs Capital Management LP now owns 775,131 shares of the company's stock worth $14,859,000 after buying an additional 18,200 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD raised its holdings in shares of Pharvaris by 36.4% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 443,896 shares of the company's stock worth $8,510,000 after buying an additional 118,408 shares in the last quarter.
Pharvaris Company Profile
(
Get Free Report)
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial.
Featured Articles
Before you consider Pharvaris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharvaris wasn't on the list.
While Pharvaris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
